Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.

Authors

Lorena Incorvaia

Lorena Incorvaia

Department of Surgical, Oncological, and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy

Lorena Incorvaia , Chiara Brando , Alessandro Perez , Marco Bono , Daniela Cancelliere , Alessia Pivetti , Nadia Barraco , Silvia Contino , Chiara Annamaria Raso , Anna Paola Carreca , Valerio Gristina , Antonio Galvano , Tancredi Didier Bazan Russo , Luisa Castellana , Lavinia Insalaco , Daniele Fanale , Claudia Marchetti , Viviana Bazan , Antonio Russo , Ignazio Carreca

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Prevention

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 10592)

DOI

10.1200/JCO.2023.41.16_suppl.10592

Abstract #

10592

Poster Bd #

225

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

First Author: Muhammad Danyal Ahsan

First Author: Jonathan Poh

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.

Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.

First Author: Jose Luis Rodriguez Olivares